Pharmaceutical compositions and methods for treating inflammation
CA 2058925 A1 · Owner: Nova Pharmaceutical Corporation · Inventors: Burch, Ronald M.; Weitzberg, Moshe
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to a method of treating an inflammatory condition for, example, atopic dermatitis, contact dermatitis psoriasis or rheumatoid arthritis, and to pharmaceutical compositions suitable for use in such a method. The pharmaceutical compositions of the invention include as an active ingredient at least one N- { ( 9H-fluoren-9-, ylmethoxy)carbonyl- amino acid or, pharmaceutically acceptable salt thereof.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed June 20, 1990. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended June 20, 2010.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 20, 2012.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.